BANGKOK, Thailand – July 8, 2026 – At WHX Labs Bangkok 2026, Wondfo showcased its latest diagnostic innovations to the Prime Minister of Thailand, Anutin Charnvirakul, with a focus on its rapid testing solutions for infectious diseases. The presentation highlighted the important role of rapid diagnostics in enabling timely disease detection and supporting public health.
Wondfo’s comprehensive infectious disease portfolio is designed to support healthcare professionals across hospitals, laboratories, and primary care settings. During the event, Prime Minister Charnvirakul received an overview of Wondfo's diagnostic technologies and their contribution to improving testing efficiency and accessibility.
A key highlight of the presentation was Wondfo's 4th Generation HIV Test, which simultaneously detects HIV-1/2 antibodies and the HIV-1 p24 antigen, enabling earlier detection than antibody-only assays. Wondfo also presented its robust colloidal gold rapid tests, covering HIV, hepatitis B, hepatitis C, syphilis, malaria, dengue, and other infectious diseases.
This engagement underscores Wondfo's dedication to advancing accessible, high-quality diagnostics. Looking ahead, Wondfo will continue to engage with relevant stakeholders in Thailand to explore donation initiatives and strategic collaboration opportunities, supporting the country's ongoing public health development.
About Wondfo
Founded in 1992, Wondfo Biotech is a leading global provider of IVD (in vitro diagnostic) solutions, dedicated to making diagnostics more accessible, efficient, and reliable. Our comprehensive portfolio includes point-of-care testing (POCT), clinical laboratory, molecular diagnostics and more, offering integrated solutions for conditions such as cardiovascular diseases, diabetes, renal disorders, respiratory diseases, drug abuse, infectious diseases, etc.
Wondfo serves healthcare professionals in over 150 countries and regions. Racing for life, Wondfo is committed to safeguarding health worldwide. Guided by this mission, we continuously advance diagnostic technologies, delivering reliable solutions that support timely clinical decisions, enhance patient outcomes and contribute to the global advancement of healthcare.
The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Single-dose Chemiluminescense Immunoassay Platform
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Ready-to-use lyophilized RT-PCR Reagent；
Wondfo PA-3600 IHC Staining System
The Wondfo Truth-H80E HPLC Hemoglobin Analyzer is a high-performance diagnostic device designed for rapid and precise measurement of glycosylated hemoglobin (HbA1c)—the gold standard for diabetes diagnosis.It support the standard mode and variant mode and provide the result within 60-90seconds.
Finecare™ Vitamin D, from complexity to simplicity
Building A World Free from Antibitoic Overuse
Advanced rapid diagnostic test with WHO prequalification for infectious disease
The Future Intelligent Medical Assistant to Healthcare
Fight against the pandemic through continuous innovation
